Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum<sup>TM</sup>.

Arthritis Res Ther · 2022 · PMC8725283 · PMID 34983619

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Flow cytometry results corroborated IMC findings and showed a trend to a greater percentage of pDCs (60.3% ± 70.98%) expressing CB2R compared to mDCs (28.10% ± 35.6%) and CD4 T cells (26.0% ± 24.0%), although not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.